Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Synthetic ERR Agonist Alleviates Metabolic Syndrome.
Billon C, Schoepke E, Avdagic A, Chatterjee A, Butler AA, Elgendy B, Walker JK, Burris TP. Billon C, et al. Among authors: avdagic a. J Pharmacol Exp Ther. 2024 Jan 17;388(2):232-240. doi: 10.1124/jpet.123.001733. J Pharmacol Exp Ther. 2024. PMID: 37739806
Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915.
Hampton CS, Sitaula S, Billon C, Haynes K, Avdagic A, Wanninayake U, Adeyemi CM, Chatterjee A, Griffett K, Banerjee S, Burris SL, Schoepke E, Boehm T, Bess A, de Vera IMS, Burris TP, Walker JK. Hampton CS, et al. Among authors: avdagic a. Eur J Med Chem. 2023 Oct 5;258:115582. doi: 10.1016/j.ejmech.2023.115582. Epub 2023 Jun 25. Eur J Med Chem. 2023. PMID: 37421886
Empirical and process-based models predict enhanced beech growth in European mountains under climate change scenarios: A multimodel approach.
Bosela M, Rubio-Cuadrado Á, Marcis P, Merganičová K, Fleischer P Jr, Forrester DI, Uhl E, Avdagić A, Bellan M, Bielak K, Bravo F, Coll L, Cseke K, Del Rio M, Dinca L, Dobor L, Drozdowski S, Giammarchi F, Gömöryová E, Ibrahimspahić A, Kašanin-Grubin M, Klopčič M, Kurylyak V, Montes F, Pach M, Ruiz-Peinado R, Skrzyszewski J, Stajic B, Stojanovic D, Svoboda M, Tonon G, Versace S, Mitrovic S, Zlatanov T, Pretzsch H, Tognetti R. Bosela M, et al. Among authors: avdagic a. Sci Total Environ. 2023 Aug 25;888:164123. doi: 10.1016/j.scitotenv.2023.164123. Epub 2023 May 13. Sci Total Environ. 2023. PMID: 37182772
Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH.
Welch RD, Billon C, Losby M, Bedia-Diaz G, Fang Y, Avdagic A, Elgendy B, Burris TP, Griffett K. Welch RD, et al. Among authors: avdagic a. Metabolites. 2022 Mar 11;12(3):238. doi: 10.3390/metabo12030238. Metabolites. 2022. PMID: 35323681 Free PMC article. Review.
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Masiukiewicz U, Charbonnel B, Frederich R, Gallo S, Cosentino F, Shih WJ, Gantz I, Terra SG, Cherney DZI, McGuire DK; VERTIS CV Investigators. Cannon CP, et al. N Engl J Med. 2020 Oct 8;383(15):1425-1435. doi: 10.1056/NEJMoa2004967. Epub 2020 Sep 23. N Engl J Med. 2020. PMID: 32966714 Clinical Trial.
RORγ regulates the NLRP3 inflammasome.
Billon C, Murray MH, Avdagic A, Burris TP. Billon C, et al. Among authors: avdagic a. J Biol Chem. 2019 Jan 4;294(1):10-19. doi: 10.1074/jbc.AC118.002127. Epub 2018 Nov 19. J Biol Chem. 2019. PMID: 30455347 Free PMC article.
15 results